+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Contraceptives Market 2019-2027

  • ID: 4772773
  • Report
  • Region: North America, United States
  • 119 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 4

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
Market Outlook

The North America contraceptive market is anticipated to show an upward trend with a compound annual growth rate of 6.46% during the estimated years 2019-2027. In the North American market, countries such as the United States and Canada have been analyzed.

The North America contraceptives market is at the topmost position on a worldwide scale. The US and Canada record a high number of unplanned pregnancies, which has made this region rank up to the topmost position. The government has undertaken various initiatives to educate the population about birth-control, along with providing access to newer drugs and devices at nominal rates. These factors largely attribute to the growth of the market. The growth of this market, however, is hindered by the occurrence of side-effects that result due to the consumption of contraceptives. The intake of certain contraceptives may even cause strokes, breast cancers, blood clots, etc. Misconceptions pertaining to the use of contraceptives has further caused market stagnancy.

The North America contraceptives market can be compartmentalized based on age group, education, drugs & devices and end users. By age group, the contraceptive market can be classified into people ranging in the ages 15-24, 25-34, 35-44 and greater than 44. On the basis of education, the market can be classified into people who are still in high school, high school graduates, college graduates and those having other college degrees. Households, clinics and hospitals are the biggest end users of contraceptives; whereas, drugs and devices include drugs such as injectables, oral pills, and topical contraceptives, and devices such as condoms (male and female), diaphragms, contraceptive sponges, vaginal rings, subdermal implants and IUDs.

Competitive Outlook

The North America contraceptive market is dominated by companies such as Okamoto Industries, Inc., SMB Corporation, Ocon Medical, Ltd., Mayer Laboratories, Inc., Church & Dwight Co., Inc., Afaxys, Inc., Melbea, Reckitt Benckiser PLC, Pfizer, Inc., Pregna, Bayer AG, Agile Therapeutics, Apothecus Pharmaceutical Corporation, Teva Pharmaceutical Industries, Ltd., Cooper Surgical, Inc., Allergan, Inc., and Merck & Co., Inc.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
1. Contraceptive Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Regulatory Outlook
2.4. Pestel Outlook
2.5. Market Attractiveness Index
2.6. Market Player Positioning
2.7. Key Insights
2.7.1. Oral Contraceptive Are the Majorly Used Contraceptive Drugs
2.7.2. Condoms Are the Widely Used Contraceptives Device
2.7.3. Age Group of 15–24 Years Are the Major Revenue Contributors to the North America Contraceptive Market
2.8. Market Drivers
2.8.1. Growing Cognizance For Contraceptives
2.8.2. Increasing Usage of Oral Contraceptives to Evade Unplanned Pregnancy
2.8.3. Surge in the Initiatives of Government and Ngo
2.8.4. Growing Awareness About Std
2.9. Market Restraints
2.9.1. Side Effects Restricting the Growth of Contraceptives
2.9.2. Limited Access to Contraceptives
2.10. Market Opportunities
2.10.1. Rising Disposable Income in Emerging Economies
2.10.2. Unmet Medical Needs in the Emerging Economies
2.10.3. Technological Advancements
2.11. Market Challenges
2.11.1. Lack of Acceptance of Society

3. Contraceptive Market Outlook - By Education
3.1. Less Than High School
3.2. High School Graduate
3.3. College Graduate
3.4. Other College Degrees

4. Contraceptive Market Outlook - By Age Group
4.1. 15–24 Years
4.2. 25–34 Years
4.3. 35–44 Years
4.4. Above 44 Years

5. Contraceptive Market Outlook - By End User
5.1. Households
5.2. Clinics
5.3. Hospitals

6. Contraceptive Market Outlook - By Drugs and Devices
6.1. Contraceptives Drugs
6.1.1. Oral Contraceptive Pills
6.1.2. Injectable Contraceptives
6.1.3. Topical Contraceptives
6.2. Contraceptive Devices
6.2.1. Male Condoms
6.2.2. Female Condoms
6.2.3. Diaphragms
6.2.4. Contraceptive Sponges
6.2.5. Vaginal Rings
6.2.6. Subdermal Implants
6.2.7. Intra-Uterine Devices
6.2.7.1. Copper Intra-Uterine Devices
6.2.7.2. Hormonal Intra-Uterine Devices

7. Contraceptive Market - Regional Outlook
7.1. North America
7.1.1. Country Analysis
7.1.2. United States
7.1.3. Canada

8. Competitive Landscape
8.1. Company Profiles
8.1.1. Allergan Inc.
8.1.2. Bayer Ag
8.1.3. Melbea
8.1.4. Pregna
8.1.5. Pfizer, Inc.
8.1.6. Church & Dwight Co., Inc.
8.1.7. Afaxys, Inc.
8.1.8. Apothecus Pharmaceutical Corporation
8.1.9. Cooper Surgical Inc
8.1.10. Okamoto Industries, Inc
8.1.11. Mayer Laboratories, Inc.
8.1.12. Agile Therapeutics
8.1.13. Merck & Co., Inc.
8.1.14. Reckitt Benckiser Plc
8.1.15. Smb Corporation
8.1.16. Teva Pharmaceutical Industries Ltd.
8.1.17. Ocon Medical Ltd

9. Methodology & Scope
9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology

List of Tables
Table 1 North America Contraceptive Market 2019-2027 ($ Million)
Table 2 Contraceptive Market Player Positioning Outlook 2017
Table 3 North America Contraceptive Market By Education 2019-2027 ($ Million)
Table 4 North America Contraceptive Market By Age Group 2019-2027 ($ Million)
Table 5 North America Contraceptive Market By End User 2019-2027 ($ Million)
Table 6 North America Contraceptive Market By Drugs and Devices 2019-2027 ($ Million)
Table 7 North America Contraceptives Drugs Market By Type 2019-2027 ($ Million)
Table 8 North America Contraceptive Devices Market By Type 2019-2027 ($ Million)
Table 9 North America Intra-Uterine Devices Market By Type 2019-2027 ($ Million)
Table 10 North America Contraceptive Market By Country 2019-2027 ($ Million)

List of Figures
Figure 1 North America Contraceptive Market 2019-2027 ($ Million)
Figure 2 Porter's Five Force Model
Figure 3 North America Contraceptive Market By Less Than High School 2019-2027 ($ Million)
Figure 4 North America Contraceptive Market By High School Graduate 2019-2027 ($ Million)
Figure 5 North America Contraceptive Market By College Graduate 2019-2027 ($ Million)
Figure 6 North America Contraceptive Market By Other College Degrees 2019-2027 ($ Million)
Figure 7 North America Contraceptive Market By 15–24 Years 2019-2027 ($ Million)
Figure 8 North America Contraceptive Market By 25–34 Years 2019-2027 ($ Million)
Figure 9 North America Contraceptive Market By 35–44 Years 2019-2027 ($ Million)
Figure 10 North America Contraceptive Market By Above 44 Years 2019-2027 ($ Million)
Figure 11 North America Contraceptive Market By Households 2019-2027 ($ Million)
Figure 12 North America Contraceptive Market By Clinics 2019-2027 ($ Million)
Figure 13 North America Contraceptive Market By Hospitals 2019-2027 ($ Million)
Figure 14 North America Contraceptive Market By Contraceptives Drugs 2019-2027 ($ Million)
Figure 15 North America Contraceptives Drugs Market By Oral Contraceptive Pills 2019-2027 ($ Million)
Figure 16 North America Contraceptives Drugs Market By Injectable Contraceptives 2019-2027 ($ Million)
Figure 17 North America Contraceptives Drugs Market By Topical Contraceptives 2019-2027 ($ Million)
Figure 18 North America Contraceptive Market By Contraceptive Devices 2019-2027 ($ Million)
Figure 19 North America Contraceptive Devices Market By Male Condoms 2019-2027 ($ Million)
Figure 20 North America Contraceptive Devices Market By Female Condoms 2019-2027 ($ Million)
Figure 21 North America Contraceptive Devices Market By Diaphragms 2019-2027 ($ Million)
Figure 22 North America Contraceptive Devices Market By Contraceptive Sponges 2019-2027 ($ Million)
Figure 23 North America Contraceptive Devices Market By Vaginal Rings 2019-2027 ($ Million)
Figure 24 North America Contraceptive Devices Market By Subdermal Implants 2019-2027 ($ Million)
Figure 25 North America Contraceptive Devices Market By Intra-Uterine Devices 2019-2027 ($ Million)
Figure 26 North America Intra-Uterine Devices Market By Copper Intra-Uterine Devices 2019-2027 ($ Million)
Figure 27 North America Intra-Uterine Devices Market By Hormonal Intra-Uterine Devices 2019-2027 ($ Million)
Figure 28 United States Contraceptive Market 2019-2027 ($ Million)
Figure 29 Canada Contraceptive Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Inc.
  • Bayer AG
  • Melbea
  • Pregna
  • Pfizer, Inc.
  • Church & Dwight Co., Inc.
  • Afaxys, Inc.
  • Apothecus Pharmaceutical Corporation
  • Cooper Surgical Inc
  • Okamoto Industries, Inc
  • Mayer Laboratories, Inc.
  • AGile Therapeutics
  • Merck & Co., Inc.
  • Reckitt Benckiser plc
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Ocon Medical
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll